{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:32:45Z","timestamp":1774686765970,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7512","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:11:10Z","timestamp":1488327070000},"page":"517-522","source":"Crossref","is-referenced-by-count":6,"title":["Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases"],"prefix":"10.2169","volume":"56","author":[{"given":"Mari","family":"Iwasaki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehito","family":"Jinnai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Komatsubara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Arisaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Tsunemi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Hiraishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Abood GJ, Go A, Malhotra D, Shoup M. The surgical and systemic management of neuroendocrine tumors of the pancreas. Surg Clin North Am 89: 249-266, 2009.","DOI":"10.1016\/j.suc.2008.10.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Park SK, O&apos;Dorisio MS, O&apos;Dorisio TM. Vasoactive intestinal polypeptide-secreting tumors: biology and therapy. Baillieres Clin Gastroenterol 10: 673-696, 1996.","DOI":"10.1016\/S0950-3528(96)90018-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Friesen SR. Update on the diagnosis and treatment of rare neuroendocrine tumors. Surg Clin North Am 67: 379-393, 1987.","DOI":"10.1016\/S0039-6109(16)44190-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50: 58-64, 2015.","DOI":"10.1007\/s00535-014-0934-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 9: 374-380, 1958.","DOI":"10.1016\/0002-9343(58)90075-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Andengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 60: 378-384, 2004.","DOI":"10.1016\/S0016-5107(04)01807-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Figueiredo FA, Giovannini M, Monges G, et al. EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endosc 70: 907-914, 2009.","DOI":"10.1016\/j.gie.2009.05.020"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience. Gastrointest Endosc 71: 1185-1193, 2010.","DOI":"10.1016\/j.gie.2009.12.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gornals J, Varas M, Catala I, et al. Definitive diagnosis of neuroendocrine tumors using fine-needle aspiration-puncture guided by endoscopic ultrasonography. Rev Esp Enferm Dig 103: 123-128, 2011.","DOI":"10.4321\/S1130-01082011000300003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hijioka S, Hara K, Mizuno N, et al. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol 51: 923-930, 2016.","DOI":"10.1007\/s00535-016-1164-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hasegawa T, Yamao K, Hijioka S, et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy 46: 32-38, 2014.","DOI":"10.1055\/s-0033-1344958"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bertani E, Fazio N, Botteri E, et al. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach. Surgery 155: 607-614, 2014.","DOI":"10.1016\/j.surg.2013.12.024"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Capurso G, Bettini R, Rinzivillo M, Boninsegna L, Delle Fave G, Falconi M. Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology 93: 223-229, 2011.","DOI":"10.1159\/000324770"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Maton PN, Gardner JD, Jensen RT. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci 34 (3 Suppl): 28S-39S, 1989.","DOI":"10.1007\/BF01536043"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Arnold R, Frank M, Kajdan U. Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues. Digestion 55: 107-113, 1994.","DOI":"10.1159\/000201211"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Debas HT, Gittes G. Somatostatin analogue in functioning neuroendocrine gut tumors. Digestion 54: 68-71, 1993.","DOI":"10.1159\/000201080"},{"key":"17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0016-5085(87)90153-3","volume":"92","author":"A Koelz","year":"1987","unstructured":"17. Koelz A, Kraenzlin M, Gyr K, et al. Escape of the response to a long-acting somatostatin analogue (SNIS 201-995) in patients with VIPoma. Gastroenterology 92: 527-531, 1987.","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lamberts SW, Pieters GF, Metselaar HJ, Ong GL, Tan HS, Reubi JC. Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumors. Acta Endocrinol 119: 561-566, 1988.","DOI":"10.1530\/acta.0.1190561"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364: 514-523, 2011.","DOI":"10.1056\/NEJMoa1009290"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364: 501-513, 2011.","DOI":"10.1056\/NEJMoa1003825"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin NE. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol 72: 517-528, 2009.","DOI":"10.1016\/j.ejrad.2008.08.008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cavallo-Perin P, De Paoli M, Guiso G, et al. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report. Cancer 62: 2576-2579, 1988.","DOI":"10.1002\/1097-0142(19881215)62:12<2576::AID-CNCR2820621221>3.0.CO;2-5"},{"key":"23","unstructured":"23. Christensen C. The somatostatin analogue SMS 201-995 in longterm treatment of vipoma. Acta Chir Scand 155: 541-543, 1989."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nguyen HN, Backers B, Lmmert F, et al. Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options. Dig Dis Sci 44: 1148-1155, 1999.","DOI":"10.1023\/A:1026672022917"},{"key":"25","unstructured":"25. Smith CS, Houston M, Jensen B, Mlinar K, Toulson C, Tillotson LG. A 32-year-old man with copious, watery diarrhea. N C Med J 62: 134-139, 2001."},{"key":"26","unstructured":"26. Sycamnias J, Strahl B, Stride P, Chern B, Paranavithana L. A case of vasoactive intestinal polypeptideoma. N Z Med J 122: 64-68, 2009."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. de Mestier L, Walter T, Brixi H, Lombard-Bohas C, Cadiot G. Sunitinib achieved fast and sustained control of VIPoma symptoms. Eur J Endocrinol 172: K1-K3, 2015.","DOI":"10.1530\/EJE-14-0682"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/5\/56_56.7512\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T05:33:27Z","timestamp":1568871207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/5\/56_56.7512\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7512","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}